Dongcheng Pharmaceutical: Sodium succinate hydrocortisone for injection undergoes evaluation for consistency in the quality and efficacy of generic drugs.

On the evening of May 6th, Dongcheng Pharmaceutical announced that recently, its wholly-owned subsidiary, Yantai Dongcheng Northern Pharmaceutical Co., Ltd. received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for sodium succinate hydrocortisone for injection. The sodium succinate hydrocortisone for injection produced by Dongcheng Northern has passed the generic drug quality and efficacy consistency evaluation.